This filing is an Initial Statement of Beneficial Ownership (Form 3) for MA XIN, the Chief Financial Officer of Bon Natural Life Ltd. The report date is April 2, 2026. MA XIN is reporting beneficial ownership of securities in Bon Natural Life Ltd. The filing indicates that there are no securities owned by the reporting...

This filing details the beneficial ownership of securities by XUE YINGCHUN, Chief Operating Officer of Bon Natural Life Ltd. The filing indicates that XUE YINGCHUN, through Lavender Oil Limited, beneficially owns 120 Class A Ordinary Shares. The shares are held indirectly, with the reporting person having a proportiona...

This filing details the ownership of Bon Natural Life Ltd by Hu Yongwei, the CEO and a director. It indicates that Hu Yongwei directly owns 2,004,427 Class B ordinary shares, which are convertible into 80,177 Class A ordinary shares at his discretion. The filing also notes that Hu Yongwei is a 10% owner of the company....

This filing details changes in beneficial ownership for Borqs Technologies, Inc. (BRQSF). Ji (Richard) Li, identified as a director, reported a post-transaction ownership of 386,615 ordinary shares. The ownership is direct. The reporting owner, Li Ji (Richard), resides in Hong Kong. The filing date was April 10, 2026, ...

This is a Form 3 initial statement of beneficial ownership filing for Ng Yah Ling, who serves as a director of CCH Holdings Ltd (ticker: CCHH). The filing was signed on April 10, 2026, with a reporting period ending March 18, 2026. Ng Yah Ling is based in Bukit Mertajam, Pulau Pinang, Malaysia, and holds the position o...

This Form 3 filing reports that Yaohui Wang, a director of CDT Environmental Technology Investment Holdings Ltd (CDTG), has no securities ownership in the company as of March 18, 2026. The filing was signed on April 10, 2026, and indicates that Wang holds the position of director but does not own any shares of the comp...

This filing reports that Marcelo Dodsworth Penna has been appointed as a director at CI&T Inc. The filing, dated April 10, 2026, indicates that Mr. Penna will hold a director position. His reporting address is listed as 800 Boylston Street, Suite 3300, Boston, MA 02199. This is an initial filing of beneficial ownership...

This filing is an initial report (Form 3) for Juan Lizardo Paredes Manrique, a director at CREDICORP LTD (BAP). The report, dated March 31, 2026, indicates that Mr. Manrique directly owns 265 common shares of the company following the transaction. No other ownership details or transactions are specified in this filing....

This filing details restricted stock units (RSUs) granted to Jin Cao, Chief Accounting Officer of Ascentage Pharma Group International. Each RSU represents a contingent right to one Ordinary Share, vesting in four equal increments on November 26th of 2026, 2027, 2028, and 2029. The filing also includes a Power of Attor...

This filing is an exhibit detailing a Power of Attorney granted by Martin Patrick Murphy, a director at Century Therapeutics, Inc. (IPSC). The document, dated December 9, 2025, and effective April 10, 2026, appoints Brent Pfeiffenberger, Douglas Carr, and Gregory Russotti as attorneys-in-fact. They are authorized to ex...

This filing details the ownership of securities by John Lawler, Chief Development Officer of Chemomab Therapeutics Ltd. (CMMB). The filing, submitted on April 10, 2026, covers the period ending March 18, 2026. It includes information on both derivative and non-derivative holdings. Lawler directly owns various stock opt...

This Form 3 filing discloses the initial statement of beneficial ownership of securities by Sigal Fattal, Chief Financial Officer of Chemomab Therapeutics Ltd. The filing shows Fattal's ownership of 9,728 American Depositary Shares (ADS) directly, plus 15,222 ADS in restricted share units (RSUs) granted on October 1, 2...

This Form 3 filing discloses the initial statement of beneficial ownership of securities by Alan Moses, a director of Chemomab Therapeutics Ltd. (CMMB). The filing reveals Moses holds six separate stock option grants to purchase American Depositary Shares, with exercise prices ranging from $2.14 to $109.04 per share. T...

This Form 3 filing discloses the securities holdings of Neil Cohen, a director of Chemomab Therapeutics Ltd. (CMMB), as of March 18, 2026. The filing reveals Cohen owns 35,304 American Depositary Shares (ADS) directly. Additionally, he holds seven separate stock option grants giving him the right to purchase ADS at var...

This filing is a Form 3, which reports initial beneficial ownership of securities. It was filed by Nissim Darvish, a director of Chemomab Therapeutics Ltd. (CMMB), on April 10, 2026. The filing details various stock options granted to Mr. Darvish, all of which are vested and exercisable. These options represent the rig...

This filing is a Form 3, which reports initial beneficial ownership of securities, by George Adi Mor, Chief Executive Officer and Director of Chemomab Therapeutics Ltd. The filing details holdings of American Depositary Shares (ADS) both directly and indirectly, including those held by his spouse. It also outlines vari...

This filing details a Power of Attorney granted by Alissa Michelle Starzak, Chief Legal Officer of Cloudflare, Inc., to various individuals. The purpose of this Power of Attorney is to allow the appointed attorneys-in-fact to complete and execute Section 16 reporting forms (Forms 3, 4, and 5) related to the ownership, ...

This Form 3 filing discloses the securities holdings of Neil Cohen, a director of Chemomab Therapeutics Ltd. (CMMB), as of March 18, 2026. The filing reveals Cohen owns 35,304 American Depositary Shares (ADS) directly. Additionally, he holds seven separate stock option grants giving him the right to purchase ADS at var...

This document is a Form 3 filing, an Initial Statement of Beneficial Ownership, for DR REDDYS LABORATORIES LTD (RDY). The reporting owner is MUNNIRPALLAM MADHU SUNDAR SUBRAMANIAN, identified by CIK 0002128817. Mr. Subramanian holds the position of Global Head of Quality and PV. The filing indicates direct ownership of ...

This filing is a Form 3, which reports initial beneficial ownership of securities. It was filed by Nissim Darvish, a director of Chemomab Therapeutics Ltd. (CMMB), on April 10, 2026. The filing details various stock options granted to Mr. Darvish, all of which are vested and exercisable. These options represent the rig...

This filing is a Form 3, which reports initial beneficial ownership of securities. E-Home Household Service Holdings Ltd (EJH) reported that ZHU CHUNSHENG, the Chief Financial Officer, acquired 1 ordinary share, holding it directly. The report details the owner's identification, address in Fuzhou, China, and confirms t...

This Form 3 filing reports that Ricardo Damian Luttini, the Chief Audit Executive of Edenor (EDN), has no securities ownership in the company as of March 18, 2026. The filing was signed on April 10, 2026, and indicates that Luttini holds no direct or indirect ownership of Edenor's securities. As a Form 3 filing, this r...

This filing is an Initial Statement of Beneficial Ownership (Form 3) for RSL Shares Trust u/a/d March 2, 2026, related to The Estee Lauder Companies Inc. The trust, identified by CIK 0002125253, holds a direct ownership stake. The reporting owner is considered a 10% owner. The filing details holdings in Class B Common ...

This filing details the ownership of EURO TECH HOLDINGS CO LTD by LEUNG TAK CHUNG. Mr. Leung, who is a director, officer, and 10% owner, reported holding 3,999,347 ordinary shares directly following a transaction. The report was filed on April 10, 2026, with the period of report being March 18, 2026....

This filing reports initial ownership of securities by LEUNG YIN LUNG, who is an officer and director of EURO TECH HOLDINGS CO LTD. The filing indicates direct ownership of 2,500 ordinary shares. Additionally, it details holdings of stock options, including one with an exercise price of $1.04 expiring on April 18, 2029...